Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Open-labelled Trial Which Aims to Show Non-inferiority of Adverse Events Risk During the Maintenance of Oral-anticoagulation in the Surgery of Benign Prostatic Hypertrophy by Laser Photovaporization

NCT03297281 is registered in ClinicalTrials.gov with Clinique Pasteur as lead sponsor.

NCT NCT03297281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03297281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Open-labelled Trial Which Aims to Show Non-inferiority of Adverse Events Risk During the Maintenance of Oral-anticoagulation in the Surgery of Benign Prostatic Hypertrophy by Laser Photovaporization
Lead sponsor
Clinique Pasteur
Phase
Not applicable
Overall status
Recruiting
Start date
October 30, 2017
Completion date
May 31, 2028
Enrollment
389 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant adverse reaction, benign prostatic hyperplasia